⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28553315 | 0.77 | — | — | |
| SCHEMBL18241872 | 0.77 | — | — | |
| SCHEMBL8860061 | 0.75 | — | — | |
| SCHEMBL29133967 | 0.75 | — | — | |
| SCHEMBL18241852 | 0.73 | — | — | |
| SCHEMBL15393209 | 0.73 | — | — | |
| SCHEMBL10561135 | 0.73 | — | — | |
| SCHEMBL29155968 | 0.71 | TSHR (0.37) | — | |
| SCHEMBL98614 | 0.71 | — | — | |
| SCHEMBL8935000 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11464758-B2 | Cannabinoid co-drug compounds | KOTZKER CONSULTING LLC (US) | 2022-10-11 | — | — | US | disclosed |
| US-20220151981-A1 | USE OF CANNABINOIDS AND TERPENES FOR TREATMENT OF ORGANOPHOSPHATE AND CARBAMATE TOXICITY | KOTZKER CONSULTING LLC (US) | 2022-05-19 | — | — | US | disclosed |
| US-11266623-B2 | Use of cannabinoids and terpenes for treatment of organophosphate and carbamate toxicity | KOTZKER CONSULTING LLC (US) | 2022-03-08 | — | — | US | disclosed |
| US-20200375940-A1 | USE OF CANNABINOIDS AND TERPENES FOR TREATMENT OF ORGANOPHOSPHATE AND CARBAMATE TOXICITY | KOTZKER CONSULTING LLC (US) | 2020-12-03 | — | — | US | disclosed |
| US-20180311205-A1 | USE OF CANNABINOIDS AND TERPENES FOR TREATMENT OF ORGANOPHOSPHATE AND CARBAMATE TOXICITY | KOTZKER CONSULTING LLC (US) | 2018-11-01 | — | — | US | disclosed |